This new weight loss drug ETF bets big on two of the industry’s leading players
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs. Roundhill Investments’ GLP-1 &…
Wall Street ponders what happens to booming private credit market when you-know-what hits the fan
The explosion of private credit has been met with a whole host of concerns, but among the louder ones more…
This ETF aims to capture China’s own ‘Magnificent Seven’
Roundhill Investments wants to mimic the success of its Magnificent Seven ETF (MAGS) in China. The firm’s CEO Dave Mazza…
These are the 3 big risks to the stock market, economist says
The U.S. stock market has been swooning. But there are risks that threaten to put a lid on the euphoria.…
Fintech nightmare: ‘I have nearly $38,000 tied up’ after Synapse bankruptcy
A dispute between a fintech startup and its banking partners has ensnared potentially millions of Americans, leaving them without access…
CFPB says buy now, pay later firms must comply with U.S. credit card laws
The Consumer Financial Protection Bureau declared on Wednesday that customers of the burgeoning buy now, pay later industry have the…
Jamie Dimon says JPMorgan stock is too expensive: ‘We’re not going to buy back a lot’
Jamie Dimon thinks shares of JPMorgan Chase are expensive. That was the message the bank’s longtime CEO gave analysts Monday…
JPMorgan CEO Jamie Dimon signals retirement is closer than ever
Jamie Dimon’s days as CEO of JPMorgan Chase are numbered — though it is unclear by how much. In a…
No ‘cop on the beat’: Why the SEC may deny new ether ETFs this month
The U.S. Securities and Exchange Commission is expected to make a key decision on approving ether exchange-traded funds next week.…
